Related Experiment Video
Updated: Jul 7, 2026

07:30
Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
Published on: November 21, 2012
Dopamine D2(High) receptors on intact cells.
1Department of Pharmacology, Medical Science Building, University of Toronto, Toronto, Ontario, Canada M5S 1A8. philip.seeman@utoronto.ca
Synapse (New York, N.Y.)
|February 5, 2008
Summary
Researchers identified a new method to detect dopamine D2(High) receptors in intact cells, crucial for understanding conditions like schizophrenia and Parkinson's disease.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Behavioral dopamine supersensitivity is observed in human neurological disorders such as schizophrenia and Parkinson's disease.
- In animal models, this supersensitivity correlates with elevated dopamine D2(High) receptors in homogenized brain tissue.
- Detecting dopamine D2(High) receptors in intact cells has remained a challenge.
Purpose of the Study:
- To develop a method for detecting dopamine D2(High) receptors in intact cells.
- To investigate the presence and detectability of dopamine D2(High) receptors in a cellular model.
Main Methods:
- Utilized [(3)H]domperidone, a radioligand, to target and detect dopamine D2(High) receptors.
- Employed intact rat anterior pituitary adenoma culture cells for receptor detection.
- Compared the efficacy of [(3)H]domperidone with [(3)H]raclopride and [(3)H]spiperone in detecting D2(High) receptors.
Main Results:
- [(3)H]domperidone successfully detected dopamine D2(High) receptors in intact rat anterior pituitary adenoma cells.
- [(3)H]raclopride and [(3)H]spiperone failed to detect D2(High) receptors in intact cells and fresh striatal slices.
- This demonstrates the utility of [(3)H]domperidone for identifying D2(High) receptors in an intact cellular system.
Conclusions:
- [(3)H]domperidone is a suitable radioligand for detecting dopamine D2(High) receptors in intact cells.
- The findings support further in vivo research into D2(High) receptor variations in human diseases.
- This method advances the study of dopamine receptor function in neurological conditions.
More Related Videos
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Spare Receptors
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Cholinergic Receptors: Nicotinic
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...

